Retrospective analysis of neuroendocrine tumors in Baotou inner mongolia

doi:10.3877/cma.j.issn.2095-7157.2021.03.005

Abstract

Abstract:

Objective

To analyze the differences in age, site, first symptoms and treatment options of neuroendocrine tumors (NEN) in Baotou area.

Methods

The clinical and pathological data of 119 patients with gastrointestinal neuroendocrine tumors admitted from 2015 to 2019 in our hospital were collected. Through retrospective analysis of the onset sex, location, symptoms and treatment measures, we provided clinical treatment for gastrointestinal neuroendocrine tumor reference.

Results

Through this study, 119 patients were retrospectively analyzed the site of the disease, symptoms and treatment measures: (1)According to different grades of value-added activity, there are not differences in age at onset, G1 stage average age is 50.89± 11.073, G2 stage average age is 61.00±12.288, G3 stage average age is 66.38±12.070; (2)The histology of esophagus, stomach and colon was different, and the incidence of the disease was significantly different (χ²=26.864, P =0, P<0.001), which was statistically significant.(3)The clinical manifestations of esophagus, stomach and colon are different due to their different diseased parts and stages.Patients with G3 stage have a foreign body sensation.Gastric G2 patients obviously have acid reflux and heartburn symptoms.Compared with patients with G1 and G2 phases, patients with colon G3 obviously have abdominal pain symptoms.There are significant differences (P<0.05); (4)8 patients (7.56%) were selected for surgical treatment, all of them were G3 patients; 111 cases (92.44%) were treated with endoscopic mucosal dissection.

Conclusion

Due to the different sites and grades of GASTROINTESTINAL NEN, the related symptoms and treatment methods of patients are different.

Key words: Neuroendocrine neoplasms, Restrospective analysis, Endoscopic submucosal dissection

Yong Wu, Tong Dang, Xianmei Meng, Zhenyu Jiang, Jing Wang, Jingjie Zhang, Yi Zhou, Yuanyuan Nian. Retrospective analysis of neuroendocrine tumors in Baotou inner mongolia[J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2021, 08(03): 111-114.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhwcnjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-7157.2021.03.005

https://zhwcnjdzzz.cma-cmc.com.cn/EN/Y2021/V08/I03/111

Figures/Tables 6

References 15

[1]	Sigel CS.Advances in the cytologic diagnosis of gastroenteropancreatic neuroendocrine neoplasms[J]. Cancer Cytopathol，2018，126(12)：980-991.
[2]	周冰，苏刚，李斌，等．胃肠道神经内分泌肿瘤的影像学表现与病理分级[J]．中国中西医结合外科杂志，2019，25(2)：127-132.
[3]	Chen P，Wang Q，Xie J，et al. Signaling networks and the feasibility of computational analysis in gastroenteropancreatic neuroendocrine tumors[C]．Seminars in cancer biology[J]. Academic Press，2019，4(5): 80-89.
[4]	努尔买买提，麦麦提吐尔逊，麦麦提艾力，等．胃68例神经内分泌肿瘤临床病理学特征及预后分析[J]．世界最新医学信息文摘，2019，19(8)，178-180.
[5]	Niederle MB,，Hackl M,，Kaserer K，et al. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters[J]. Endocr Relat Cancer，2010，17(4): 909-918.
[6]	李剑昂，韩序，方圆，等．胃神经内分泌肿瘤的临床病理学特征与预后分析[J]．中华胃肠外科杂志，2014，13(10)：784-788.
[7]	谭煌英，娄彦妮，罗杰．胃神经内分泌肿瘤的分型诊断和治疗[J]．世界华人消化杂志，2016，24(22)，3329-3336.
[8]	谭煌英．胃神经内分泌肿瘤临床分型的共识和争议[J]. 中华胃肠外科杂志，2017，20(9)，1671-0274.
[9]	中国临床肿瘤学会神经内分泌肿瘤专家委员会. 中国胃肠胰神经内分泌肿瘤专家共识(2016年版)[J]. 临床肿瘤学杂志，2016，21(10)：927-946.
[10]	王振江，古毓娴，任彦先．胃神经内分泌肿瘤的研究进展[J/CD]．中华腔镜外科杂志(电子版)，2019，12(6)，380-384.
[11]	Irvin M,，Modlin I,，Michael D，et al.Siegfried oberndorfer: Origins andperspectives of carcinoid tumors[J]．Hum Pathol，2004，35(12): 1440-1451.
[12]	郭花，王海红，李娜，等．胃肠道神经内分泌肿瘤的内镜下诊断与治疗[J]．胃肠病学和肝病学杂志，2014，23(9)：1010-1014.
[13]	Mantese G．Gastrointestinal stromal tumor：epidemiology diagnosis and treatment[J]．Curr Opin Gastroenterol，2019，35 (6): 555- 559.
[14]	Toshirou Nishida,，Osamu Goto,，Chandrajit Premanand Raut，et al.Diagnostic and treatment strategy for small gastrointestinal stromal tumors[J]. Cancer，2016，122(20)：3110-3118.
[15]	Cho JW.Current Guidelines in the Management of Upper Gastrointestinal Subepithelial Tumors[J]. Clin Endosc，2016，49(3)：235- 240.

分型	例数	年龄(±s，岁)	性别[岁(%)]
分型	例数	年龄(±s，岁)	男	女
G1	107	62.42±13.42	61(57.01)	46(42.99)
G2	4	54±2.3	3(75)	1(25)
G3	8	68±13.1	7(87.50)	1(12.50)
统计值		F＝1.519	χ²＝3.066
P值		0.223	0.190

分型	例数	年龄(±s，岁)	性别[岁(%)]
分型	例数	年龄(±s，岁)	男	女
G1	107	62.42±13.42	61(57.01)	46(42.99)
G2	4	54±2.3	3(75)	1(25)
G3	8	68±13.1	7(87.50)	1(12.50)
统计值		F＝1.519	χ²＝3.066
P值		0.223	0.190

分型	例数	直径(cm)	是否转移
分型	例数	直径(cm)	转移	未转移
G1	107	1.0±0.31	0	107(100)
G2	4	3.3±1.9^a	0	4(100)
G3	8	4.55±2.36^ab	5(62.5)^ab	3(37.5)
统计值		F＝106.423	χ²＝72.418
P值		<0.001	<0.001

分型	例数	直径(cm)	是否转移
分型	例数	直径(cm)	转移	未转移
G1	107	1.0±0.31	0	107(100)
G2	4	3.3±1.9^a	0	4(100)
G3	8	4.55±2.36^ab	5(62.5)^ab	3(37.5)
统计值		F＝106.423	χ²＝72.418
P值		<0.001	<0.001

发病部位	例数	G1	G2	G3
食管	3	0	0	3(100)
胃	12	8(66.66)	2(16.67)	2(16.67)
肠	104	99(95.19)	2(1.92)	3(2.89)
χ²值		26.864
P值		<0.001

Please choose a citation manager

Content to export